CMG Pharmaceutical Co. Ltd (058820) - Total Liabilities

Latest as of December 2025: ₩104.41 Billion KRW ≈ $70.75 Million USD

Based on the latest financial reports, CMG Pharmaceutical Co. Ltd (058820) has total liabilities worth ₩104.41 Billion KRW (≈ $70.75 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

CMG Pharmaceutical Co. Ltd - Total Liabilities Trend (2011–2025)

This chart illustrates how CMG Pharmaceutical Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See working capital position of CMG Pharmaceutical Co. Ltd to evaluate short-term liquidity relative to the company's equity base.

CMG Pharmaceutical Co. Ltd Competitors by Total Liabilities

The table below lists competitors of CMG Pharmaceutical Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Bertrandt Aktiengesellschaft XETRA:BDT	Germany	€451.97 Million
Novus Holdings Ltd JSE:NVS	South Africa	ZAC1.61 Billion
SHANGHAI FUDAN H YC-,10 F:FDY	Germany	€273.93 Million
Kestrel Group, Ltd. NYSE:KG	USA	$986.67 Million
Vranken-Pommery Monopole Société Anonyme PA:VRAP	France	€927.49 Million
CLERHP Estructuras S.A MC:CLR	Spain	€74.25 Million
MEI Pharma Inc NASDAQ:MEIP	USA	$1.35 Million
Arbe Robotics Ltd NASDAQ:ARBE	USA	$34.71 Million

Liability Composition Analysis (2011–2025)

This chart breaks down CMG Pharmaceutical Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 058820 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.92	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.52	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.34	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how CMG Pharmaceutical Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for CMG Pharmaceutical Co. Ltd (2011–2025)

The table below shows the annual total liabilities of CMG Pharmaceutical Co. Ltd from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩104.41 Billion ≈ $70.75 Million	-8.33%
2024-12-31	₩113.89 Billion ≈ $77.18 Million	+119.60%
2023-12-31	₩51.87 Billion ≈ $35.15 Million	+83.22%
2022-12-31	₩28.31 Billion ≈ $19.18 Million	+95.60%
2021-12-31	₩14.47 Billion ≈ $9.81 Million	+1.74%
2020-12-31	₩14.22 Billion ≈ $9.64 Million	+17.71%
2019-12-31	₩12.08 Billion ≈ $8.19 Million	+16.22%
2018-12-31	₩10.40 Billion ≈ $7.05 Million	-10.55%
2017-12-31	₩11.62 Billion ≈ $7.88 Million	+17.75%
2016-12-31	₩9.87 Billion ≈ $6.69 Million	+1.50%
2015-12-31	₩9.73 Billion ≈ $6.59 Million	+7.28%
2014-12-31	₩9.07 Billion ≈ $6.14 Million	+31.10%
2013-12-31	₩6.92 Billion ≈ $4.69 Million	-72.90%
2012-12-31	₩25.52 Billion ≈ $17.29 Million	+175.24%
2011-12-31	₩9.27 Billion ≈ $6.28 Million	--

About CMG Pharmaceutical Co. Ltd

KQ:058820 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$100.89 Million

₩148.88 Billion KRW

Market Cap Rank

#19207 Global

#924 in Korea

Share Price

₩1007.00

Change (1 day)

-5.89%

52-Week Range

₩1007.00 - ₩2140.00

All Time High

₩8318.64